Sort by:

select Language:



Global Tuberculosis Report 2019

World Health Organization WHO, (2019)


New data on tuberculosis trends in 202 countries TB remains one of the top 10 causes of death worldwide. Millions of people continue to fall sick from TB each year. The Global TB Report 2019 provides a comprehensive and up-to-date assessment of the TB epidemic, and progress in the response, at global, regional and country levels. It features data on disease trends and the response to the epidemic in 202 countries and territories. The Global Report includes trends in TB incidence and mortality, data on case detection and treatment results for TB, multidrug-resistant TB (MDR-TB), TB/HIV, TB prevention, universal health coverage as well as financing. It presents progress towards targets set at the first-ever United Nations General Assembly high-level meeting on TB in 2018, that brought together heads of state, as well as the targets of the WHO End TB Strategy and the Sustainable Development Goals. The report also includes an overview of pipelines for new TB diagnostics, drugs and vaccines. Additionally, it outlines a monitoring framework that features data on SDG indicators that can be used to identify key influences on the TB epidemic at national level and inform the multi-sectoral actions required to end the TB epidemic
https://apps.who.int/iris/bitstream/handle/10665/3...


Global Tuberculosis Report 2019. Exceutive Summary

World Health Organization WHO, (2019)


New data on tuberculosis trends in 202 countries TB remains one of the top 10 causes of death worldwide. Millions of people continue to fall sick from TB each year. The Global TB Report 2019 provides a comprehensive and up-to-date assessment of the TB epidemic, and progress in the response, at global, regional and country levels. It features data on disease trends and the response to the epidemic in 202 countries and territories. The Global Report includes trends in TB incidence and mortality, data on case detection and treatment results for TB, multidrug-resistant TB (MDR-TB), TB/HIV, TB prevention, universal health coverage as well as financing. It presents progress towards targets set at the first-ever United Nations General Assembly high-level meeting on TB in 2018, that brought together heads of state, as well as the targets of the WHO End TB Strategy and the Sustainable Development Goals. The report also includes an overview of pipelines for new TB diagnostics, drugs and vaccines. Additionally, it outlines a monitoring framework that features data on SDG indicators that can be used to identify key influences on the TB epidemic at national level and inform the multi-sectoral actions required to end the TB epidemic
https://www.who.int/tb/publications/global_report/...


Доклад о глобальной борьбе с туберкулезом 2017 год

World Health Organization, Eds.: World Health Organization, (2017)


Глобальный доклад о туберкулезе ВОЗ призван дать всеобъемлющую и актуальную оценку эпидемии туберкулеза (ТБ) и достижений в области его лечения и профилактики на глобальном, региональном и страновом уровнях.
https://www.who.int/tb/publications/global_report/...


Global Tuberculosis Report 2018

World Health Organization WHO, (2018)


WHO has published a global TB report every year since 1997. The main aim of the report is to provide a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease at global, regional and country levels. This is done in the context of recommended global TB strategies and targets endorsed by WHO’s Member States and broader development goals set by the United Nations (UN)
http://apps.who.int/iris/bitstream/handle/10665/27...


Tuberculosis surveillance and monitoring in Europe 2018

WHO Regional Office for Europe (WHO/Europe) and the European Centre for Disease Prevention and Control (ECDC)., (2018)


In 2016, 58 994 cases of TB were reported in 30 EU/EEA countries (Liechtenstein did not report). The decreasing notification rates observed in most countries are reassuring, but annual rates of decline are still insufficient to achieve the WHO target of TB elimination by 2050 in European low-incidence countries. Of all notified TB cases, 70.4% were newly diagnosed and 71.0% were confirmed by culture, smear or nucleic acid amplification test. Thirty-three per cent of all TB cases were of foreign origin, mostly residing in low-incidence countries. Overall, adult age groups were equally affected by TB. Children under 15 years of age accounted for 4.1% of all TB cases, corresponding to a notification rate of 3.0 per 100 000 population. Multidrug-resistant (MDR) TB was reported for 3.7% of 36 071 cases with drug susceptibility testing (DST) results and continues to be highest (more than 10%) in the three Baltic countries. Extensively drug-resistant (XDR) TB was reported for 20.1% of 984 MDR TB cases tested for secondline drug susceptibility. The drug resistance for the second line anti-TB drugs has slightly increased compared to recent years
https://ecdc.europa.eu/sites/portal/files/document...


Methods used by WHO to estimate the global burden of TB disease

P. Glaziou, C.Sismanidis, P. J. Dodd, et al., Eds.: World Health Organization; University of Sheffield, (2017)


30 October 2017
http://www.who.int/entity/tb/publications/global_r...


20 hits